Lantheus
LNTH
Collegium Pharmaceutical
COLL
Constellation Brands
STZ
4
Halozyme Therapeutics
HALO
5
AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
US Stock MarketDetailed Quotes
DAITF DAITO PHARMACEUTICAL CO.LTD
- 13.130
- 0.0000.00%
15min DelayClose Jan 3 16:00 ET
199.95MMarket Cap11.30P/E (TTM)
0.000High0.000Low0Volume0.000Open13.130Pre Close0.00Turnover0.00%Turnover Ratio9.21P/E (Static)15.23MShares13.13052wk High0.00P/B199.95MFloat Cap13.13052wk Low0.43Dividend TTM15.23MShs Float13.130Historical High3.31%Div YieldTTM0.00%Amplitude13.130Historical Low--Avg Price1Lot Size
DAITO PHARMACEUTICAL CO.LTD Key Stats
Quarterly+Annual
YOY
| (FY)May 31, 2024 | (FY)May 31, 2023 | (FY)May 31, 2022 | (FY)May 31, 2021 | (FY)May 31, 2020 | (FY)May 31, 2019 | (FY)May 31, 2018 | (FY)May 31, 2017 | (FY)May 31, 2016 | (FY)May 31, 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | ||||||||||
| Net income from continuing operations | -16.90%4.22B | -24.46%5.08B | 14.42%6.72B | 4.97%5.87B | 21.14%5.6B | 8.34%4.62B | 9.73%4.26B | 13.40%3.89B | 1.58%3.43B | 17.54%3.37B |
| Other non cash items | -23.23%-244M | -137.57%-198M | 177.50%527M | -228.73%-680M | 319.30%528.23M | 49.69%-240.87M | -180.34%-478.79M | 438.06%595.94M | 11.23%-176.28M | -255.67%-198.57M |
| Change In working capital | 51.59%-1.13B | 47.12%-2.33B | -177.89%-4.4B | 62.49%-1.58B | -883.89%-4.22B | 37.35%538.36M | 118.42%391.97M | -16.65%-2.13B | -123.24%-1.82B | 57.25%-817.07M |
| -Change in receivables | 161.85%929M | 54.47%-1.5B | -221.15%-3.3B | 180.82%2.72B | -455.43%-3.37B | 107.17%947.95M | 164.34%457.57M | -185.73%-711.21M | 186.21%829.58M | 64.12%-962.25M |
| -Change in inventory | -86.84%-2.64B | -35.73%-1.41B | 71.16%-1.04B | -73.89%-3.61B | -176.36%-2.08B | 7.87%-750.99M | 45.98%-815.12M | 7.53%-1.51B | -78.17%-1.63B | -118.83%-915.81M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 24.72%5.18B | -4.92%4.16B | -15.67%4.37B | 20.34%5.18B | -37.48%4.31B | 26.03%6.89B | 7.80%5.47B | 71.92%5.07B | -21.14%2.95B | 36.24%3.74B |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | ||||||||||
| Net PPE purchase and sale | -12.99%-6.22B | -18.98%-5.51B | 26.76%-4.63B | -131.33%-6.32B | 24.77%-2.73B | 3.28%-3.63B | -25.44%-3.75B | 24.22%-2.99B | 19.26%-3.95B | -109.50%-4.89B |
| Net intangibles purchase and sale | -9.80%-56M | 51.89%-51M | -241.94%-106M | 26.43%-31M | -29.11%-42.14M | 36.77%-32.64M | ---51.61M | ---- | ---- | ---- |
| Net investment purchase and sale | --335M | ---- | 5,020.00%256M | -94.87%5M | 145.89%97.46M | -1,598.97%-212.37M | ---12.5M | ---- | -111.89%-41.29M | 56.09%347.37M |
| Net other investing changes | 210.00%11M | -112.99%-10M | 285.00%77M | 456.19%20M | -172.49%-5.62M | 149.16%7.75M | 19.93%-15.76M | 22.08%-19.68M | 51.09%-25.25M | -1.32%-51.63M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -6.54%-5.93B | -26.50%-5.57B | 30.42%-4.4B | -135.84%-6.32B | 30.67%-2.68B | -0.90%-3.87B | -27.27%-3.83B | 24.99%-3.01B | 12.61%-4.02B | -112.45%-4.59B |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | ||||||||||
| Net issuance payments of debt | 44.71%1.97B | 2,332.14%1.36B | -80.56%56M | 115.55%288M | 24.05%-1.85B | -118.64%-2.44B | 23.37%-1.12B | -245.88%-1.46B | 180.97%997.71M | 11.27%-1.23B |
| Net common stock issuance | -712.50%-1.18B | -87.32%192M | -15.80%1.51B | -10.12%1.8B | 452,668.10%2B | 57.21%-442K | -54.18%-1.03M | 70.87%-670K | -100.09%-2.3M | 3,045,993.83%2.47B |
| Cash dividends paid | 2.58%-907M | -41.06%-931M | -0.30%-660M | -31.06%-658M | -11.39%-502.07M | -9.25%-450.74M | -9.94%-412.56M | -0.18%-375.26M | 19.64%-374.6M | -57.51%-466.17M |
| Net other financing activities | 50.00%-1M | -102.50%-2M | 4,100.00%80M | -125.53%-2M | 783,600.00%7.84M | ---1K | ---- | 34.25%97.8M | 3,642,600.00%72.85M | 0.00%-2K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -129.71%-183M | -37.71%616M | -30.55%989M | 506.32%1.42B | 87.91%-350.46M | -87.75%-2.9B | 13.17%-1.54B | -437.77%-1.78B | 4.66%526.3M | 124.35%502.89M |
| Net cash flow | ||||||||||
| Beginning cash position | -17.67%3.61B | 29.92%4.38B | 9.34%3.37B | 69.50%3.08B | 6.31%1.82B | 5.82%1.71B | 19.70%1.62B | -29.58%1.35B | -16.05%1.92B | -38.20%2.29B |
| Current changes in cash | -17.11%-931M | -182.90%-795M | 240.07%959M | -77.87%282M | 939.22%1.27B | 38.31%122.63M | -68.36%88.66M | 151.89%280.21M | -53.28%-539.99M | 76.25%-352.3M |
| Effect of exchange rate changes | 155.00%51M | -58.33%20M | 860.00%48M | 151.59%5M | 33.80%-9.69M | -368.70%-14.64M | 138.91%5.45M | 49.31%-14M | -89.11%-27.62M | -120.71%-14.61M |
| End cash Position | -24.40%2.73B | -17.67%3.61B | 29.92%4.38B | 9.33%3.37B | 69.51%3.08B | 6.31%1.82B | 5.82%1.71B | 19.70%1.62B | -29.58%1.35B | -16.05%1.92B |
| Free cash flow | 21.91%-1.09B | -285.95%-1.4B | 68.89%-363M | -176.13%-1.17B | -52.47%1.53B | 102.64%3.23B | -23.39%1.59B | 307.81%2.08B | 15.26%-999.75M | -387.91%-1.18B |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
Trending Stocks
Discussing
FOMC leaves rates unchanged, how will you adjust your portfolio?
FOMC left the target Federal Funds rate unchanged at at target of 4.25%-4.5%, how will you adjust your portfolio?
Moo Live
Jan 30 03:25
FOMC Press Conference, January 29, 2025